Home › ZEUS SCIENTIFIC, INC. › Parvovirus B19 IgG/IgM

Parvovirus B19 IgG/IgM

ZEUS SCIENTIFIC, INC. · Model V119IF · UDI-DI 00845533003438

Prescription

510(k) clearances

Adverse events

Recalls

Facilities

Description

The Parvovirus B19 Immunofluorescent Assay is intended for the qualitative and semi-quantitative detection of anti-Parvovirus B19 IgG and IgM antibodies in human serum. The test is indicated for use in all women where there is a suspicion of exposure to Parvovirus B19 to determine the presence of a recent or current infection.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API key Read the docs

Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.